|
Originally published In Press as doi:10.1194/jlr.R400017-JLR200 on February 1, 2005
Journal of Lipid Research, Vol. 46, 389-403, March 2005
Copyright © 2005 by American Society for Biochemistry and Molecular Biology
Thematic review series: The Immune System and Atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease?
Alan Chait1,
Chang Yeop Han,
John F. Oram and
Jay W. Heinecke
Division of Metabolism, Endocrinology, and Nutrition, Department of Medicine, University of Washington, Seattle, WA 98195
1 To whom correspondence should be addressed. e-mail: achait{at}u.washington.edu
In humans, a chronically increased circulating level of C-reactive protein (CRP), a positive acute-phase reactant, is an independent risk factor for cardiovascular disease. This observation has led to considerable interest in the role of inflammatory proteins in atherosclerosis. In this review, after discussing CRP, we focus on the potential role in the pathogenesis of human vascular disease of inflammation-induced proteins that are carried by lipoproteins. Serum amyloid A (SAA) is transported predominantly on HDL, and levels of this protein increase markedly during acute and chronic inflammation in both animals and humans. Increased SAA levels predict the risk of cardiovascular disease in humans. Recent animal studies support the proposal that SAA plays a role in atherogenesis. Evidence is accruing that secretory phospholipase A2, an HDL-associated protein, and platelet-activating factor acetylhydrolase, a protein associated predominantly with LDL in humans and HDL in mice, might also play roles both as markers and mediators of human atherosclerosis. In contrast to positive acute-phase proteins, which increase in abundance during inflammation, negative acute-phase proteins have received less attention. Apolipoprotein A-I (apoA-I), the major apolipoprotein of HDL, decreases during inflammation. Recent studies also indicate that HDL is oxidized by myeloperoxidase in patients with established atherosclerosis. These alterations may limit the ability of apoA-I to participate in reverse cholesterol transport. Paraoxonase-1 (PON1), another HDL-associated protein, also decreases during inflammation. PON1 is atheroprotective in animal models of hypercholesterolemia. Controversy over its utility as a marker of human atherosclerosis may reflect the fact that enzyme activity rather than blood level (or genotype) is the major determinant of cardiovascular risk. Thus, multiple lipoprotein-associated proteins that change in concentration during acute and chronic inflammation may serve as markers of cardiovascular disease.
In future studies, it will be important to determine whether these proteins play a causal role in atherogenesis.
Supplementary key words inflammation C-reactive protein serum amyloid A apolipoprotein A-I high density lipoprotein paraoxonase-1 secretory phospholipase A2 platelet-activating factor acetylhydrolase myeloperoxidase

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. W. Heinecke
The HDL proteome: a marker-and perhaps mediator-of coronary artery disease
J. Lipid Res.,
April 1, 2009;
50(Supplement):
S167 - S171.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Wang, H. Chai, Z. Wang, P. H. Lin, Q. Yao, and C. Chen
Serum amyloid A induces endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells
Am J Physiol Heart Circ Physiol,
December 1, 2008;
295(6):
H2399 - H2408.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A Meyers, A. Y Liu, A. McTiernan, M. H Wener, B. Wood, D. S Weigle, B. Sorensen, Z. Chen-Levy, Y. Yasui, A. Boynton, et al.
Serum leptin concentrations and markers of immune function in overweight or obese postmenopausal women
J. Endocrinol.,
October 1, 2008;
199(1):
51 - 60.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Fujita
Association between Protein Levels and Mortality in Patients with Peripheral Arterial Disease
Ann Intern Med,
July 1, 2008;
149(1):
64 - 64.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Aslim, T. Hakki Akay, B. Basturk, S. Ozkan, B. Gultekin, S. Ozcobanoglu, S. Sirvan, and S. Aslamaci
The Role of Antiendothelial Cell Antibodies in the Development and Follow-up of Coronary and Peripheral Arterial Diseases
Angiology,
May 1, 2008;
59(2):
209 - 213.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Stahlman, P. Davidsson, I. Kanmert, B. Rosengren, J. Boren, B. Fagerberg, and G. Camejo
Proteomics and lipids of lipoproteins isolated at low salt concentrations in D2O/sucrose or in KBr
J. Lipid Res.,
February 1, 2008;
49(2):
481 - 490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Hu, S. Abe-Dohmae, M. Tsujita, N. Iwamoto, O. Ogikubo, T. Otsuka, Y. Kumon, and S. Yokoyama
Biogenesis of HDL by SAA is dependent on ABCA1 in the liver in vivo
J. Lipid Res.,
February 1, 2008;
49(2):
386 - 393.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Van Lenten, A. C. Wagner, M. Navab, G. M. Anantharamaiah, S. Hama, S. T. Reddy, and A. M. Fogelman
Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits
J. Lipid Res.,
November 1, 2007;
48(11):
2344 - 2353.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. F. Tacer, D. Kuzman, M. Seliskar, D. Pompon, and D. Rozman
TNF-{alpha} interferes with lipid homeostasis and activates acute and proatherogenic processes
Physiol Genomics,
October 19, 2007;
31(2):
216 - 227.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Boekhoorn, J. R. Vingerling, J. C. M. Witteman, A. Hofman, and P. T. V. M. de Jong
C-reactive Protein Level and Risk of Aging Macula Disorder: The Rotterdam Study
Arch Ophthalmol,
October 1, 2007;
125(10):
1396 - 1401.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Spirou, E. Rizos, E. N. Liberopoulos, N. Kolaitis, A. Achimastos, A. D. Tselepis, and M. Elisaf
Effect of Barnidipine on Blood Pressure and Serum Metabolic Parameters in Patients With Essential Hypertension: A Pilot Study
Journal of Cardiovascular Pharmacology and Therapeutics,
December 1, 2006;
11(4):
256 - 261.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Turgeon, M. C. Carr, P. M. Maki, M. E. Mendelsohn, and P. M. Wise
Complex Actions of Sex Steroids in Adipose Tissue, the Cardiovascular System, and Brain: Insights from Basic Science and Clinical Studies
Endocr. Rev.,
October 1, 2006;
27(6):
575 - 605.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Venteclef, J. C. Smith, B. Goodwin, and P. Delerive
Liver receptor homolog 1 is a negative regulator of the hepatic acute-phase response.
Mol. Cell. Biol.,
September 1, 2006;
26(18):
6799 - 6807.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. Lyle and K. K. Griendling
Modulation of vascular smooth muscle signaling by reactive oxygen species.
Physiology,
August 1, 2006;
21:
269 - 280.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Jernas, J. Palming, K. Sjoholm, E. Jennische, P.-A. Svensson, B. G. Gabrielsson, M. Levin, A. Sjogren, M. Rudemo, T. C. Lystig, et al.
Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression
FASEB J,
July 1, 2006;
20(9):
1540 - 1542.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Wilson, C. L. L. Pham, A. J. Jenkins, J. D. Wade, A. F. Hill, M. A. Perugini, and G. J. Howlett
High density lipoproteins bind A{beta} and apolipoprotein C-II amyloid fibrils
J. Lipid Res.,
April 1, 2006;
47(4):
755 - 760.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Phan, O. Ivanovski, T. Nguyen-Khoa, N. Mothu, J. Angulo, R. Westenfeld, M. Ketteler, N. Meert, J. Maizel, I. G. Nikolov, et al.
Sevelamer Prevents Uremia-Enhanced Atherosclerosis Progression in Apolipoprotein E-Deficient Mice
Circulation,
November 1, 2005;
112(18):
2875 - 2882.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Nashed, B. Yeganeh, K. T. HayGlass, and M. H. Moghadasian
Antiatherogenic Effects of Dietary Plant Sterols Are Associated with Inhibition of Proinflammatory Cytokine Production in Apo E-KO Mice
J. Nutr.,
October 1, 2005;
135(10):
2438 - 2444.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bhat, M. G. Sorci-Thomas, E. T. Alexander, M. P. Samuel, and M. J. Thomas
Intermolecular Contact between Globular N-terminal Fold and C-terminal Domain of ApoA-I Stabilizes Its Lipid-bound Conformation: STUDIES EMPLOYING CHEMICAL CROSS-LINKING AND MASS SPECTROMETRY
J. Biol. Chem.,
September 23, 2005;
280(38):
33015 - 33025.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Binder, P. X. Shaw, M.-K. Chang, A. Boullier, K. Hartvigsen, S. Horkko, Y. I. Miller, D. A. Woelkers, M. Corr, and J. L. Witztum
Thematic review series: The Immune System and Atherogenesis. The role of natural antibodies in atherogenesis
J. Lipid Res.,
July 1, 2005;
46(7):
1353 - 1363.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|